Hands Off my Data: How to Protect Sensitive Information in the Biotech Industry

Add bookmark

Intellectual property is the life sciences industry’s most important asset, because it forms the basis of product approvals and of cooperation, licensing and due diligence negotiations. That is why life sciences firms need to protect their knowledge while making it available to certain third parties. How can they achieve this delicate balancing act from a technical viewpoint? This is where specialists from the IT industry come in, as they can create and manage virtual worlds on demand and help companies provide highly selective access to their data. One of these providers is the German-based company Brainloop, which already works with several well-known biotech firms. Brigitte Ehret, Sales Director for the Life Science Industry at Brainloop, talked to us about meeting the particular requirements of the biotech industry and ensuring confidential information is protected.

Latest Webinars

Pharma IQ's Power List 2022: In conversation with pharma's top leaders

2022-10-18

02:00 PM - 03:00 PM BST

Join us to hear from the most influential people in pharma today, as voted for by you

A post-pandemic 3D view of the patient and supply journey

2022-06-01

04:30 PM - 05:30 PM CET

In this panel discussion with experts from 4G Clinical, THREAD Research and World Courier, learn how...

Discover how targeted radiotherapy induced toxicity can be identified with imaging

2022-04-28

01:00 PM - 02:00 PM EST

This Pharma IQ webinar with AIQ explores how AI-assisted analysis of radiological scans enhances the...

Recommended